Roos K, Håkansson E G, Holm S
Ear, Nose, and Throat Department, Lundby Hospital, 41717 Gothenburg, Sweden.
BMJ. 2001 Jan 27;322(7280):210-2. doi: 10.1136/bmj.322.7280.210.
To study the effect of recolonisation with alpha streptococci with the ability to inhibit the growth of otopathogens ("interfering" activity) on the recurrence of acute otitis media in susceptible children and the effect on the frequency of secretory otitis media.
Double blind, randomised, placebo controlled study.
Ear, nose, and throat clinic with three doctors.
130 children prone to otitis media aged between 6 months and 6 years, 108 of whom were eligible and followed for 3 months.
Recurrence of otitis media during follow up and a normal tympanic membrane at the last valid visit.
Children with no recurrences during the last month received phenoxymethylpenicillin (n=22), and those with a recurrence within 1 month received amoxicillin clavulanic acid (n=86), both twice daily for 10 days. These were followed by a streptococcal or placebo solution sprayed into the nose for a further 10 days. At day 60 the same spray was started for another 10 days.
At 3 months 22 children (42%) given the streptococcal spray were healthy and had a normal tympanic membrane compared with 12 (22%) of those given placebo. This difference was shown separately for recurrences of both acute otitis media and secretory otitis media.
Selected bacteria with the ability to inhibit the growth of common otopathogens can be used to protect against recurrent acute otitis media and secretory otitis media in children.
研究具有抑制耳病原体生长能力(“干扰”活性)的α链球菌再定植对易感儿童急性中耳炎复发的影响以及对分泌性中耳炎发病率的影响。
双盲、随机、安慰剂对照研究。
有三名医生的耳鼻喉科诊所。
130名6个月至6岁易患中耳炎的儿童,其中108名符合条件并随访3个月。
随访期间中耳炎的复发情况以及最后一次有效访视时鼓膜正常。
过去一个月内未复发的儿童接受苯氧甲基青霉素治疗(n = 22),过去1个月内复发的儿童接受阿莫西林克拉维酸治疗(n = 86),均每日两次,共10天。之后再用链球菌溶液或安慰剂溶液喷鼻10天。在第60天,再次开始相同的喷雾治疗10天。
3个月时,接受链球菌喷雾治疗的22名儿童(42%)健康且鼓膜正常,而接受安慰剂治疗的儿童中这一比例为12名(22%)。急性中耳炎和分泌性中耳炎的复发情况分别显示出这种差异。
具有抑制常见耳病原体生长能力的特定细菌可用于预防儿童复发性急性中耳炎和分泌性中耳炎。